Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

ClinicalTrials.gov ID: NCT00196365

Public ClinicalTrials.gov record NCT00196365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval Compared to Conventional Oral Contraceptive Therapy for Cyclic Pelvic Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9 months. Patients will be required to record menstrual pain in a daily diary.

Study identification

NCT ID
NCT00196365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
97 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Jul 2007 (Actual)
Completion
Jul 2007 (Actual)
Last update posted
May 12, 2014

2005 – 2007

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801 —
Duramed Investigational Site Phoenix Arizona 85032 —
Duramed Investigational Site San Diego California 92108 —
Duramed Investigational Site Denver Colorado 80202 —
Duramed Investigational Site Tampa Florida 33607 —
Duramed Investigational Site Decatur Georgia 30034 —
Duramed Investigational Site Moorestown New Jersey 08057 —
Duramed Investigational Site Charlotte North Carolina 28222 —
Duramed Investigational Site Columbus Ohio 43205 —
Duramed Investigational Site Columbus Ohio 43213 —
Duramed Investigational Site Medford Oregon 97504 —
Duramed Investigational Site Philadelphia Pennsylvania 19114 —
Duramed Investigational Site Memphis Tennessee 38120 —
Duramed Investigational Site Salt Lake City Utah 84124 —
Duramed Investigational Site Newport News Virginia 23602 —
Duramed Investigational Site Norfolk Virginia 23507 —
Duramed Investigational Site Spokane Washington 99207 —
Duramed Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00196365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →